Browse our 650+ Publications​

Latest Publications

Cutaneous T-cell lymphomas with pathogenic somatic mutations and absence of detectable clonal T-cell receptor gene rearrangement: two case reports

Rojansky R., et al.
Diagnostic Pathology
October 2020
Authors and Affiliates
Rebecca Rojansky 1, Sebastian Fernandez-Pol 1, Erica Wang 2, Kerri E Rieger 1,2, Roberto A Novoa 1,2, James L Zehnder 1,3, Christian A Kunder 1, Youn H Kim 2,4, Michael S Khodadoust 2,4, Ryanne A Brown 5,6,7; 1 Department of Pathology, Stanford Medicine, Stanford, CA, 94305, USA. 2 Department of Dermatology, Stanford Medicine, Stanford, CA, 94305, USA. 3 Division of Hematology, Department of Medicine, Stanford Medicine, Stanford, CA, 94305, USA. 4 Division of Oncology, Department of Medicine, Stanford Medicine, Stanford, CA, 94305, USA. 5 Department of Pathology, Stanford Medicine, Stanford, CA, 94305, USA. rbrown85@stanford.edu. 6 Department of Dermatology, Stanford Medicine, Stanford, CA, 94305, USA. rbrown85@stanford.edu. 7 Department of Pathology, Veterans Affairs Palo Alto Health Care System, 3375 Hillview Ave, Room 1821, Palo Alto, CA, 94304-1204, USA. rbrown85@stanford.edu.

CDK4/6 inhibition enhances antitumor efficacy of chemotherapy and immune checkpoint inhibitor combinations in preclinical models and enhances T-cell activation in patients with SCLC receiving chemotherapy

Lai AY., et al.
Journal for ImmunoTherapy of Cancer
October 2020
Authors and Affiliates
Anne Y Lai 1, Jessica A Sorrentino 2, Konstantin H Dragnev 3, Jared M Weiss 4, Taofeek K Owonikoko 5, Julie A Rytlewski 6, Jill Hood 6, Zhao Yang 1, Rajesh K Malik 1, Jay C Strum 1, Patrick J Roberts 1; 1 Research and Development, G1 Therapeutics, Inc, Research Triangle Park, North Carolina, USA. 2 Research and Development, G1 Therapeutics, Inc, Research Triangle Park, North Carolina, USA jsorrentino@g1therapeutics.com. 3 Department of Hematology and Oncology, Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA. 4 Division of Hematology and Oncology, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA. 5 Department of Hematology and Medical Oncology, Emory University Winship Cancer Institute, Atlanta, Georgia, USA. 6 Life Sciences Research, Adaptive Biotechnologies Corp, Seattle, Washington, USA.

mRNA vaccine-induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer

Cafri G., et al.
JCI
Journal of Clinical Investigation
October 2020
Authors and Affiliates
Gal Cafri 1 2, Jared J Gartner 1, Tal Zaks 3, Kristen Hopson 3, Noam Levin 1, Biman C Paria 1, Maria R Parkhurst 1, Rami Yossef 1, Frank J Lowery 1, Mohammad S Jafferji 1, Todd D Prickett 1, Stephanie L Goff 1, Christine T McGowan 1, Samantha Seitter 1, Mackenzie L Shindorf 1, Anup Parikh 1, Praveen D Chatani 1, Paul F Robbins 1, Steven A Rosenberg 1; 1 Surgery Branch, National Cancer Institute (NCI), NIH, Bethesda, Maryland, USA. 2 Sheba Medical Center, Ramat Gan, Israel. 3 Moderna Inc., Cambridge, Massachusetts, USA.

Analysis of the Heterogeneity of CD4+CD25+ T Cell TCR β CDR3 Repertoires in Breast Tumor Tissues, Lung Metastatic Tissues, and Spleens from 4T1 Tumor-Bearing BALB/c Mice

Zhang T,. et al.
Journal of Immunology Research
October 2020
Authors and Affiliates
Teng Zhang 1 2, Fangfang Duan 2, Danhua Su 2, Long Ma 2, Jiezuan Yang 3, Bin Shi 4, Xiaoyan He 2, Rui Ma 2, Suhong Sun 1, Xinsheng Yao 2; 1 Department of Breast Surgery, The Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China 2 Department of Immunology, Research Center for Medicine & Biology, Innovation & Practice Base for Graduate Students Education, Zunyi Medical University, Zunyi, Guizhou, China 3 Department of Infectious Diseases, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China 4 Department of Laboratory Medicine, Zunyi Medical University, Zunyi, Guizhou, China

Lymphocytic infiltration in stage II microsatellite stable colorectal tumors: A retrospective prognosis biomarker analysis

Sanz-Pamplona R., et al.
PLOS Medicine
September 2020
Authors and Affiliates
Rebeca Sanz-Pamplona 1,2,3, Marilena Melas 4, Asaf Maoz 5, Stephanie L Schmit 6, Hedy Rennert 7, Flavio Lejbkowicz 7, Joel K Greenson 8, Xavier Sanjuan 9, Maria Lopez-Zambrano 9, M Henar Alonso 1,2,3 10, Chenxu Qu 11, Kevin J McDonnell 11, Gregory E Idos 11, Marissa Vignali 12, Ryan Emerson 12, Paul Fields 12, Elisabet Guinó 1,2,3, Cristina Santos 1,2,13, Ramon Salazar 1,2,13, Harlan S Robins 12,14, Gad Rennert 7, Stephen B Gruber 11, Victor Moreno 1,2,3,10; 1 Catalan Institute of Oncology (ICO), Hospitalet de Llobregat, Barcelona, Spain. 2 ONCOBELL Program, Bellvitge Biomedical Research Institute (IDIBELL), Hospitalet de Llobregat, Barcelona, Spain. 3 Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Spain. 4 Nationwide Children's Hospital, Columbus, Ohio, United States of America. 5 Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, United States of America. 6 H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States of America. 7 Carmel Medical Center, and Technion, Haifa, Israel. 8 University of Michigan Medical School, Ann Arbor, Michigan, United States of America. 9 University Hospital Bellvitge (HUB-IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain. 10 Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Barcelona, Spain. 11 City of Hope National Medical Center, Duarte, California, United States of America. 12 Adaptive Biotechnologies, Seattle, Washington, United States of America. 13 Consortium for Biomedical Research in Oncology (CIBERONC), Spain. 14 Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.

Serial Assessment of Circulating T lymphocyte Phenotype and Receptor Repertoire During Treatment of Non-Muscle Invasive Bladder Cancer with Adoptive T Cell Immunotherapy

Wang X., et al.
September 2020
Authors and Affiliates
Xiaoli Wang 1, Guoliang Qiao 1, Ni Jiang 1, Michael A Morse 2, Xinna Zhou 1, Shuo Wang 1, Jiangping Wu 1, Yuguang Song 1, Yanjie Zhao 1, Lei Zhou 1, Yanhua Yuan 1, Amy Hobeika 2, Jun Ren 1, Herbert Kim Lyerly 1; 1 Capital Medical University Affiliated Beijing Shijitan Hospital, Beijing, China 2 Duke University Medical Center, Durham, NC, USA

Human thymic T cell repertoire is imprinted with strong convergence to shared sequences

Heikkilä N., et al.
Molecular Immunology
September 2020
Authors and Affiliates
Nelli Heikkilä a,*, Reetta Vanhanen b, Dawit A. Yohannes c, Iivari Kleino d, Ilkka P. Mattila e, Jari Saramäki f, T. Petteri Arstila g; a Research Programs Unit, Translational Immunology and Medicum, Department of Bacteriology and Immunology, University of Helsinki. Haartmaninkatu 3, 00290 Helsinki, Finland b Research Programs Unit, Translational Immunology and Medicum, Department of Bacteriology and Immunology, University of Helsinki. Haartmaninkatu 3, 00290 Helsinki, Finland c Research Programs Unit, Translational Immunology and Medicum, Department of Medical and Clinical Genetics, University of Helsinki. Haartmaninkatu 8, 00290 Helsinki, Finland d Research Programs Unit, Translational Immunology, University of Helsinki. Haartmaninkatu 3, 00290 Helsinki, Finland e Department of Pediatric Cardiac and Transplantation Surgery, Hospital for Children and Adolescents, Helsinki University Central Hospital. Stenbäckinkatu 9, 00290 Helsinki, Finland f Department of Computer Science, Aalto University. Konemiehentie 2, 02150 Espoo, Finland g Research Programs Unit, Translational Immunology and Medicum, Department of Bacteriology and Immunology, University of Helsinki. Haartmaninkatu 3, 00290 Helsinki, Finland

Exhaustion of tumour-infiltrating T-cell receptor repertoirediversity is an age-dependent indicator of immunological fit-ness independently predictive of clinical outcome in Burkittlymphoma

Rieken J., et al.
British Journal of Haematology
September 2020
Authors and Affiliates
Johannes Rieken 1, Veronica Bernard 2, Hanno M Witte 1,3, Wolfgang Peter 4, Hartmut Merz 2, Vito Olschewski 1, Lars Hertel 5, Hendrik Lehnert 6, Harald Biersack 1, Nikolas von Bubnoff 1, Alfred C Feller 2, Niklas Gebauer 1; 1 Department of Haematology and Oncology, University Hospital of Schleswig-Holstein, Luebeck, Germany. 2 Hämatopathologie Lübeck, Reference Centre for Lymph Node Pathology and Haematopathology, Lübeck, Germany. 3 Department of Haematology and Oncology, Federal Armed Hospital Ulm, Ulm, Germany. 4 HLA Typing Laboratory of the Stefan-Morsch-Foundation, Birkenfeld, Germany. 5 Department of Neuro- and Bioinformatics, University Hospital of Schleswig-Holstein, Luebeck, Germany. 6 Department of Internal Medicine I, University Hospital of Schleswig-Holstein, Luebeck, Germany.

CBFB-MYH11 fusion neoantigen enables T cell recognition and killing of acute myeloid leukemia

Biernacki MA., et al.
JCI
Journal of Clinical Investigation
September 2020
Authors and Affiliates
Melinda A Biernacki 1,2, Kimberly A Foster 1, Kyle B Woodward 1, Michael E Coon 1, Carrie Cummings 1, Tanya M Cunningham 1, Robson G Dossa 1, Michelle Brault 1, Jamie Stokke 1,3, Tayla M Olsen 1, Kelda Gardner 2, Elihu Estey 1,2, Soheil Meshinchi 1,3, Anthony Rongvaux 1,4, Marie Bleakley 1,3; 1 Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. 2 Department of Medicine. 3 Department of Pediatrics, and. 4 Department of Immunology, University of Washington, Seattle, Washington, USA.

IL-32γ potentiates tumor immunity in melanoma

Gruber T., et al.
JCI Insight
September 2020
Authors and Affiliates
Thomas Gruber 1,2, Mirela Kremenovic 1,2, Hassan Sadozai 1,2, Nives Rombini 1, Lukas Baeriswyl 1, Fabienne Maibach 1, Robert L Modlin 3, Michel Gilliet 4, Diego von Werdt 1,2, Robert E Hunger 5, S Morteza Seyed Jafari 5, Giulia Parisi 6, Gabriel Abril-Rodriguez 6, Antoni Ribas 6, Mirjam Schenk 1; 1 Institute of Pathology, Experimental Pathology, and. 2 Graduate School Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland. 3 Division of Dermatology, Department of Medicine and Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine at UCLA, Los Angeles, California, USA. 4 Department of Dermatology, Lausanne University Hospital, Lausanne, Switzerland. 5 Department of Dermatology, Inselspital, University Hospital of Bern, University of Bern, Bern, Switzerland. 6 Division of Hematology-Oncology, Department of Medicine, David Geffen School of Medicine at UCLA, and UCLA Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, USA.
Previous Next